Watchlist Price Alert

Aquestive Therapeutics In... (AQST)

NASDAQ: AQST · Real-Time Price · USD

3.50

-0.04 (-1.13%)

At close: Jun 17, 2025, 12:22 PM

Aquestive Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-44.14M	-7.87M	-54.41M	-70.54M	-55.78M	-66.25M	-61.38M	-8.94M	-9.6M
Depreciation & Amortization	718K	1.34M	2.39M	2.96M	3.44M	2.9M	3.24M	3.8M	3.89M
Stock-Based Compensation	7.1M	2.69M	4.38M	6.82M	6.58M	7.07M	29.94M	n/a	n/a
Other Working Capital	-14.56M	-259K	24.77M	3.56M	-828K	1.6M	-1.49M	1.38M	152K
Other Non-Cash Items	10.52M	2.8M	5.85M	15.69M	4.71M	2.29M	1.93M	3.08M	3.83M
Deferred Income Tax	n/a	n/a	n/a	13.82M	n/a	4.9M	5.28M	n/a	n/a
Change in Working Capital	-9.96M	-5.34M	32.01M	-1.73M	-4.41M	-11.12M	8M	7.88M	-6.29M
Operating Cash Flow	-35.76M	-6.38M	-9.79M	-32.98M	-45.46M	-60.21M	-12.99M	5.82M	-8.18M
Capital Expenditures	-159K	-995K	-2.52M	-913K	-517K	-663K	-1.82M	-2.07M	-976K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.17M
Other Investing Acitivies	n/a	n/a	-1.5M	n/a	n/a	n/a	n/a	n/a	1.17M
Investing Cash Flow	-159K	-995K	-2.52M	-913K	-517K	-663K	-1.82M	-2.07M	190K
Debt Repayment	-23K	-20.39M	n/a	n/a	-22.5M	17.06M	n/a	5M	6.94M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.1M	15.45M	-2.02M	329K	51.06M	35.37M	-10.79M	-586K	-1.25M
Financial Cash Flow	83.59M	3.97M	11.56M	30.11M	28.46M	49.6M	58.03M	4.41M	5.69M
Net Cash Flow	47.67M	-3.4M	-751K	-3.78M	-17.52M	-11.27M	43.22M	8.17M	-2.3M
Free Cash Flow	-35.92M	-7.38M	-12.31M	-33.89M	-45.98M	-60.87M	-14.81M	3.76M	-9.15M